Ontology highlight
ABSTRACT: Background
Whether left ventricular hypertrophy (LVH) is determined by similar genomic and environmental risk factors with stroke, or is simply an intermediate stroke marker, is unknown.Objectives
We present a research plan and preliminary findings to explore the overlap in the genomic and environmental determinants of LVH and stroke among Africans participating in the SIREN (Stroke Investigative Research and Education Network) study.Methods
SIREN is a transnational, multicenter study involving acute stroke patients and age-, ethnicity-, and sex-matched control subjects recruited from 9 sites in Ghana and Nigeria. Genomic and environmental risk factors and other relevant phenotypes for stroke and LVH are being collected and compared using standard techniques.Results
This preliminary analysis included only 725 stroke patients (mean age 59.1 ± 13.2 years; 54.3% male). Fifty-five percent of the stroke subjects had LVH with greater proportion among women (51.6% vs. 48.4%; p < 0.001). Those with LVH were younger (57.9 ± 12.8 vs. 60.6 ± 13.4; p = 0.006) and had higher mean systolic and diastolic blood pressure (167.1/99.5 mm Hg vs 151.7/90.6 mm Hg; p < 0.001). Uncontrolled blood pressure at presentation was prevalent in subjects with LVH (76.2% vs. 57.7%; p < 0.001). Significant independent predictors of LVH were age <45 years (adjusted odds ratio [AOR]: 1.91; 95% confidence interval [CI]: 1.14 to 3.19), female sex (AOR: 2.01; 95% CI: 1.44 to 2.81), and diastolic blood pressure > 90 mm Hg (AOR: 2.10; 95% CI: 1.39 to 3.19; p < 0.001).Conclusions
The prevalence of LVH was high among stroke patients especially the younger ones, suggesting a genetic component to LVH. Hypertension was a major modifiable risk factor for stroke as well as LVH. It is envisaged that the SIREN project will elucidate polygenic overlap (if present) between LVH and stroke among Africans, thereby defining the role of LVH as a putative intermediate cardiovascular phenotype and therapeutic target to inform interventions to reduce stroke risk in populations of African ancestry.
SUBMITTER: Adeoye AM
PROVIDER: S-EPMC5583025 | biostudies-literature | 2017 Jun
REPOSITORIES: biostudies-literature
Adeoye Abiodun M AM Ovbiagele Bruce B Kolo Philip P Appiah Lambert L Aje Akinyemi A Adebayo Oladimeji O Sarfo Fred F Akinyemi Joshua J Adekunle Gregory G Agyekum Francis F Shidali Vincent V Ogah Okechukwu O Lackland Dan D Gebregziabher Mulugeta M Arnett Donna D Tiwari Hemant K HK Akinyemi Rufus R Olagoke Ojo Olakanmi OO Oguntade Ayodipupo Sikiru AS Olunuga Taiwo T Uwanruochi Kelechi K Jenkins Carolyn C Adadey Patrick P Iheonye Henry H Owolabi Lukman L Obiako Reginald R Akinjopo Samuel S Armstrong Kevin K Akpalu Albert A Fakunle Adekunle A Saulson Raelle R Aridegbe Mayowa M Olowoyo Paul P Osaigbovo Godwin G Akpalu Josephine J Fawale Bimbo B Adebayo Philip P Arulogun Oyedunni O Ibinaiye Philip P Agunloye Atinuke A Ishaq Naser N Wahab Kolawole K Akpa Onoja O Adeleye Omisore O Bock-Oruma Andrew A Ogbole Godwin G Melikam Sylvia S Yaria Joseph J Ogunjimi Luqman L Salaam Abdul A Sunmonu Taofiki T Makanjuola Akintomiwa A Farombi Temitope T Laryea Ruth R Uvere Ezinne E Kehinde Salaam S Chukwuonye Innocent I Azuh Paschal P Komolafe Morenikeji M Akintunde Adeseye A Obiabo Olugbo O Areo Olusegun O Kehinde Issa I Amusa Adeniyi G AG Owolabi Mayowa M
Global heart 20170313 2
<h4>Background</h4>Whether left ventricular hypertrophy (LVH) is determined by similar genomic and environmental risk factors with stroke, or is simply an intermediate stroke marker, is unknown.<h4>Objectives</h4>We present a research plan and preliminary findings to explore the overlap in the genomic and environmental determinants of LVH and stroke among Africans participating in the SIREN (Stroke Investigative Research and Education Network) study.<h4>Methods</h4>SIREN is a transnational, mult ...[more]